Skip to main content
IRTC logo

IRTC · iRhythm Holdings, Inc.

Track IRTC — free
$126.44 +3.28 (+2.66%) At close · Aug 14
Market Cap
$4.17B
Shares
32.96M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$126.44 Open$123.45 Day$120.54–128.00 52W close$101.79–189.25 Avg vol 30d645K Short int3.2M · 9.7% float · 6.6d Short vol73% Last earningsAug 6, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 9, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg −9%
      below
      Price vs 50-day avg +9%
      above
      RSI (14) 58
      neutral
      MACD trend Positive
      52-week position 28%
      mid-range
      Momentum
      relative strength
      Weak
      1-month return +14%
      trailing
      6-month return −10%
      trailing
      YTD return −29%
      this year
      Relative strength −24%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $116 › 200d $139 — 200d above 50d
      Institutional flow Distributing
      -1% holders QoQ · +45 funds added
      Insider flow Distributing
      Net -$7.9M over 90 days · 100% sells
      Short interest Falling
      9.75% of float · ▼ -6.3% MoM · 6.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      302 holders — mid 3-yr range
      Squeeze score 72
      high risk · 0–100
      Fundamentals
      Excellent
      Revenue growth +26%
      Y/Y
      Gross margin 71%
      expanding
      EPS growth +62%
      Y/Y
      Free cash flow $34.5M
      Balance sheet $201.1M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 42%
      annualized · 1-yr
      Max drawdown −46%
      past year
      ATR 4.7%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 6, 2026
      Revenue · full year 2026 $880M – $890M
      Adjusted EBITDA margin · full year 2026 Non-GAAP 13% – 14%
      Prior guidance period ended · from the Earnings Call filed Mar 31, 2026
      Adjusted EBITDA margin · second quarter, 2026 11.5% – 12.5%
      Guided vs delivered · last 1 settled
      Full year revenue full year 2024
      guided $575M – $585M
      $591.84M Beat +2.0%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 3 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −9% Bearish
      Price vs 50-day avg
      +9% Bullish
      RSI (14)
      58 Neutral
      MACD trend
      Positive Bullish
      52-week position
      28% Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $116 › 200d $139 — 200d above 50d
      Institutional flow Distributing
      -1% holders QoQ · +45 funds added
      Insider flow Distributing
      Net -$7.9M over 90 days · 100% sells
      Short interest Falling
      9.75% of float · ▼ -6.3% MoM · 6.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      302 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $102 Now $126 · 28% Range high $189
      vs 200-day avg -9% vs 50-day avg +9%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Free cash flow non-GAAP $34.5M Full Year 2025

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      IRTC
      iRhythm Holdings, Inc.
      this stock
      $4.17B -28.7% +26.2% 9.7%
      ABT
      Abbott Laboratories
      $194.07B -11.2% +5.7% 31.2 1.3%
      SYK
      Stryker Corp
      $133.18B -3.5% +11.2% 36.0 2.2%
      MDT
      Medtronic plc
      $116.83B -5.0% +8.4% 24.5 1.4%
      BSX
      Boston Scientific Corp
      $75.11B -45.6% +12.5% 21.0 1.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      302
      % held
      108.3%
      Net QoQ
      -3.7K sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      321
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      3.2M
      Days to cover
      6.6d
      Change
      -217.6K sh
      View
      Short Volume
      Short vol %
      73%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      4
      Value
      $500
      As of
      Jul 8, 2026
      View
      Off-Exchange
      Off-exchange %
      48.9%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$7.9M
      Buyers / Sellers
      0 / 9
      Buyers Sellers
      View
      Congressional Trades Sell
      Member
      Donna Shalala
      Amount
      $1.0K–$15.0K
      Traded
      Jun 24, 2019
      View
      Financials
      Financials
      Revenue (FY)
      $747.1M
      Net income (FY)
      $-45.0M
      EPS diluted
      $-1.39
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 13, 2026
      This year
      16
      View
      Proposed Sales
      Value
      $626.4K
      Shares
      5.3K
      Filed
      May 11, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 6, 2026
      View
      Investor Relations
      Latest news
      iRhythm to Acquire VitalConnect,…
      Published
      Aug 6, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      IRTC -1.1% +14.0% -10.5% +7.9% -28.7%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -1.5% +9.6% -24.2% +4.0% -42.6%
      Key facts CIK 1388658 CUSIP 450056106 13F (30d) 292 filings 289 filers Visit website Investor relations